a developer of therapeutics for endocrine-related diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with FOLD. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then FOLD could also see price increases.
Ticker / NAME | Correlation To CRNX | 1D Price Change % | ||
---|---|---|---|---|
CRNX | 100% | -1.96% | ||
FOLD - CRNX | 38% Loosely correlated | +0.17% | ||
PRME - CRNX | 38% Loosely correlated | -9.81% | ||
NTLA - CRNX | 36% Loosely correlated | -3.65% | ||
EDIT - CRNX | 34% Loosely correlated | -6.68% | ||
BBIO - CRNX | 33% Poorly correlated | +3.20% | ||
More |
Ticker / NAME | Correlation To CRNX | 1D Price Change % |
---|---|---|
CRNX | 100% | -1.96% |
therapeutics theme (57 stocks) | 38% Loosely correlated | +20.54% |
pharmaceuticals theme (167 stocks) | 38% Loosely correlated | +0.82% |
diseases theme (42 stocks) | 36% Loosely correlated | +1.03% |